Fig. 2From: A cost-utility analysis of long-acting insulin analogues (detemir, glargine and degludec) for the treatment of adult type 1 diabetes in South AfricaProbabilistic sensitivity analysis results Degludec vs Glargine U300 (USD, 2021 prices)Back to article page